Midgard Science

Labs / ADME, DMPK & toxicology

Grove Biopharma

Chicago, IL, United States · grovebiopharma.com

Grove Biopharma develops Bionic Biologics™, a synthetic biologics platform for targeting intracellular protein-protein interactions. It is based in Chicago, with compute infrastructure in Toronto, and works on therapeutics for cancer, neurodegenerative diseases, rare disorders, and myocardial infarction.

They take quote requests by email.

What they offer

  • AI-enabled molecular design

    Uses AI/ML and physics-based computational design to identify target-binding peptides and design molecules against challenging targets.

  • Precision polymer chemistry

    Assembles peptide inputs into protein-scale molecules through a novel precision polymerization process.

  • Experimental biology

    Combines experimental biology with the platform to create proprietary Bionic Biologics against intracellular protein-protein interaction targets.

What they work on

Modalities
Small molecule, Antibody, Bispecific, Peptide
Species and models
animal models, rodent
Assays and studies
structural biology, phage display, small-angle X-ray scattering (SAXS)
Therapeutic areas
cancer, neurodegenerative diseases, rare disorders, myocardial infarction
Sites
Chicago, USA · Toronto, Canada
Founded
2025

Similar labs. Sparx BIO, AbTherx, Aurigene Pharmaceutical Services, Bioneeds

Found in a contract services directory. Listing built from grovebiopharma.com. Work here? Claim this listing.

Grove Biopharma · Midgard Science